Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify subjects who are highly sensitized with antibodies.
It is difficult for these patients to find suitable kidneys. We propose to treat such
patients to decrease the antibodies in such a way, that it may become possible to safely
transplant kidneys into them.